Treatment and Management of Dementia Due to Alzheimer’s Disease

Keywords

Dementia, Medicine, Disease, Neurology, Psychological intervention

References

• Burden of Behavioral and Psychiatric Symptoms in People Screened Positive for Dementia in Primary Care: Results of the DelpHi-StudyJochen René Thyrian, Tilly Eichler, Johannes Hertel — 2015
• Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.Nhi‐Ha Trinh, Jennifer Hoblyn, Subhanjoy Mohanty — 2003
• Alzheimer’s DementiaVijaya L. Melnick, Nancy Neveloff Dubler — 1985
• The evaluation and management of the acutely agitated elderly patient.Denise Nassisi, Beatriz Korc, Sigrid A. Hahn — 2006
• A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's DiseaseSimona Gabriella Di Santo, Federica Prinelli, Fulvio Adorni — 2013
• Targeting and Managing Behavioral Symptoms in Individuals with Dementia: A Randomized Trial of a Nonpharmacologic InterventionLaura N. Gitlin, Laraine Winter, Marie P. Dennis — 2010
• The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-Analysis of Randomized Placebo-Controlled TrialsHui Ma, Yinglin Huang, Zhengtu Cong — 2014
• Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-AnalysisChen‐Chen Tan, Jin‐Tai Yu, Hui-Fu Wang — 2014
• Long-term Effects of Galantamine on Cognitive Function in Alzheimer's Disease: A Large-Scale International Retrospective StudyShane Kavanagh, B. Van Baelen, Barbara Schäuble — 2011
• Antidepressants for agitation and psychosis in dementia.Dallas Seitz, Nikesh Adunuri, Sudeep S. Gill — 2011
• The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.Clive Ballard, Jonathan Waite, Jacqueline Birks — 2002
• Reengineering advance care planning to create scalable, patient- and family-centered interventions.Jared Chiarchiaro, Robert M. Arnold, Douglas B. White — 2015
• Depression in dementia: epidemiology, mechanisms, and treatmentDaniela Enache, Bengt Winblad, Dag Aarsland — 2011
• Adherence to Medication in Patients with DementiaSönke Arlt, Reinhard Lindner, Alexander Rösler — 2008
• Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.Fabricio Ferreira de Oliveira, Paulo Henrique Ferreira Bertolucci, Elizabeth Chen — 2014
• Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert PanelHelen C. Kales, Laura N. Gitlin, Constantine G. Lyketsos — 2014
• Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.Gordon Wilcock, Clive Ballard, James A. Cooper — 2008
• The Clinical Dementia Rating (CDR)John C. Morris — 1993
• Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s diseaseKaren Marder — 2007
• Update on the Pharmacological Treatment of Alzheimer’s DiseaseFadi Massoud, Serge Gauthier — 2010

Cited by

• Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease.Sai‐Sai Xie, Jinshuai Lan, Xiaobing Wang — 2016
• Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.Jinshuai Lan, Yue Ding, Yun Liu — 2017
• Induction treatment strategy in multiple sclerosis: a review of past experiences and future perspectivesSerena Ruggieri, Simona Pontecorvo, Carla Tortorella — 2018
• Determining the Temporal Profile of Intracranial Pressure Changes Following Transient Stroke in an Ovine ModelAnnabel Sorby‐Adams, Anna V. Leonard, Levi E. Elms — 2019
• Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril AssemblyNishad Thamban Chandrika, Marina Y. Fosso, Oleg V. Tsodikov — 2019
• Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in GermanyChristian Rausch, Falk Hoffmann — 2020
• [Non-pharmacological treatment of cognitive impairment].Primitivo Ramos Cordero, Raquel Yubero — 2016
• The impact of music-based intervention on cognitive function and brain functional magnetic resonance imaging in people with mild Alzheimer's diseaseJihui Lyu, Wenbo Zhang, Jie De — 2025

Related papers

• [The incidence of reversible dementia in 145 patients referred on suspicion of dementia].Pia Würtzen Norup, Jan W. Kufahl, Jens Bülow Feilberg — 2002
• When Memory Fails: Helping the Alzheimer's and Dementia PatientA. J. Edwards — 1994
• Dementia risk prediction: are we there yet?Sanjeev M. Kamat, Anjali S. Kamat, George T. Grossberg — 2010
• Analyzing the chance of developing dementia among geriatric people: a cross‐sectional pilot study in BangladeshMd. Sahab Uddin, Abdullah Al Mamun, Shinya Takeda — 2018
• Trends of dementia in hospitals with specialized outpatients with dementiaMasayoshi Kawai, Yuko Sano, Jun‐ichi Ogasawara — 2017
• Challenges of diagnosing dementia in the oldest old population.Melissa J. Slavin, Henry Brodaty, Perminder S. Sachdev — 2013
• Survey of Dementia Awareness and Needs in Seongdong-gu Regional Center for DementiaHan Jo Kim, Ki‐Bong Park, Seung‐Hyun Kim — 2008
• Different Patterns of Cerebral Injury in Dementia with or Without DiabetesJoshua A. Sonnen — 2009